FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/11/029049 [Registered on: 11/11/2020] Trial Registered Prospectively
Last Modified On: 20/05/2021
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   A prospective, observational study to assess the functional recovery, duration of hospital stays, and complications of patients undergoing Robot assisted Total Hip Replacement surgery 
Scientific Title of Study   A prospective, observational study to assess the functional recovery, duration of hospital stays, and complications of Robot assisted Total Hip Replacement surgery in patients 20 years and above (with fusion of capital epiphysis) in India – A pilot investigator initiated study. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashish Singh 
Designation  Consultant Orthopedic Surgeon and Director 
Affiliation  Anup Institute of Orthopedics and Rehabilitation 
Address  Ground Floor, OPD Complex, R No 117,Anup Institute of Orthopedics and Rehabilitation, (AIOR) G 75, 77, P C Colony Rd, Kankarbagh, Bankman Colony, Patna, Bihar 800020, India

Patna
BIHAR
800020
India 
Phone  8294240349  
Fax    
Email  drashishsingh@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashish Singh 
Designation  Consultant Orthopedic Surgeon and Director 
Affiliation  Anup Institute of Orthopedics and Rehabilitation 
Address  Ground Floor, OPD Complex, R No 117,Anup Institute of Orthopedics and Rehabilitation, (AIOR) G 75, 77, P C Colony Rd, Kankarbagh, Bankman Colony, Patna, Bihar 800020, India

Patna
BIHAR
800020
India 
Phone  8294240349  
Fax    
Email  drashishsingh@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ashish Singh 
Designation  Consultant Orthopedic Surgeon and Director 
Affiliation  Anup Institute of Orthopedics and Rehabilitation 
Address  Ground Floor, OPD Complex, R No 117,Anup Institute of Orthopedics and Rehabilitation, (AIOR) G 75, 77, P C Colony Rd, Kankarbagh, Bankman Colony, Patna, Bihar 800020, India

Patna
BIHAR
800020
India 
Phone  8294240349  
Fax    
Email  drashishsingh@hotmail.com  
 
Source of Monetary or Material Support  
Anup Institute of Orthopedics and Rehabilitation 
 
Primary Sponsor  
Name  Anup Institute of Orthopedics and Rehabilitation 
Address  Anup Institute of Orthopedics and Rehabilitation, (AIOR) G 75, 77, P C Colony Rd, Kankarbagh, Bankman Colony, Patna, Bihar 800020, India  
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashish Singh  Anup Institute of Orthopedics and Rehabilitation  Ground Floor, OPD Complex, R No 117,Anup Institute of Orthopedics and Rehabilitation, (AIOR) G 75, 77, P C Colony Rd, Kankarbagh, Bankman Colony, Patna, Bihar 800020, India
Patna
BIHAR 
8294240349

drashishsingh@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, Anup Institute of Orthopedics and Rehabilitation  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M169||Osteoarthritis of hip, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Patients undergoing total hip arthroplasty.
2. Male and female aged 20 years and above (with fusion of capital epiphysis)
3. Subject is willing to take part in the study by signing Ethics Committee (EC) approved informed consent form (ICF)
4. Subjects agrees to comply with postoperative scheduled clinical and radiographic evaluation
 
 
ExclusionCriteria 
Details  1. Patient with an active infection within the affected hip joint
2. Patient with neuromuscular or neurosensory deficiency that may affect the ability to evaluate the study end points.
3. Patients who are known drug or alcohol abusers or with psychological disorders that could affect follow up care or treatment outcomes.
4. Patients with history of deep vein thrombosis or other thrombotic disorders.
5. Patients for whom the surgical procedure is a revision of a previous THA
6. Clinical signs of a coexisting severe acute systemic illness (Pneumonia, sepsis, UTI, other co-morbidities)
7. Diagnosis of immune deficiency (AIDS, other congenital
immunodeficiency syndrome, drug therapy with steroids, anticancer drugs etc.)
8. Participation in another clinical study within 30 days before the beginning or anytime during the duration of the current clinical study.
9. Patient is unlikely to adhere to study procedures, keep appointments, or is planning to relocate during the study.
10. Any other reason that in the opinion of the investigator may interfere with the evaluation required by the study.
11. Patient identified as employee of the Investigator or study center as well as family members (i.e. immediate, husband, wife and their children, adopted or natural) of the employees or the Investigator
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To observe the functional recovery, duration of hospital stay and complications of Robotic assisted technology in patients undergoing THA  Baseline, 5 days post op, 6 week, 3 and 6 month, 1,2,3 and 5 year 
 
Secondary Outcome  
Outcome  TimePoints 
1. Changes in pain levels as reported by patients between pre-operation (baseline) and post-operation during the course of the study (before discharge and post-surgery
2. Total time taken for surgery
3. Amount of blood loss during surgery
4. Bone measurements
5. Patients requiring spinal vs general anesthesia
6. Patients diagnosed with Deep vein thrombosis
7. Patients with infections despite Antibiotic prophylaxis
9. Implant defects
 
one, two, three and five years 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/11/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="6"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This prospective, observational, Investigator Initiated study will be conducted at a study site under the Principal Investigator.  The study aims to assess the functional outcomes and complications of patients undergoing robotic Total Hip replacement

 


 
Close